Nagore G. Olaciregui

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

Faizaan Mohammad, Simon Weissmann, Benjamin Leblanc et al. · Nature Medicine · 2017 · 530 citations

Medicine, Cancer Biology, Oncology +14

Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models

Tammy Hennika, Guo Hu, Nagore G. Olaciregui et al. · PLoS ONE · 2017 · 189 citations · Full text

Medicine, Oncology, Pharmacology +17

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma

Diana Carvalho, Kathryn R. Taylor, Nagore G. Olaciregui et al. · Communications Biology · 2019 · 122 citations · Full text

Medicine, Oncology, Pharmacology +7

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Guillem Pascual‐Pasto, Miriam Bazán‐Peregrino, Nagore G. Olaciregui et al. · Science Translational Medicine · 2019 · 113 citations · Full text

Medicine, Oncology, Ophthalmology +16

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma

Justyna M. Przystal, Sajee Waramit, Md Zahidul Islam Pranjol et al. · EMBO Molecular Medicine · 2019 · 83 citations · Full text

Medicine, Oncology, Pharmacology +17